Abstract
Background: There are no published guidelines for the pharmacological management of insomnia in the pediatric population, and there are no Food and Drug Administration (FDA) approved medications for this purpose. Yet, many classes of psychopharmacological medications are used off-label in children and adolescents.
Objective: To describe the side effects of different classes of medications used as sleep aids in the pediatric population, and management of those side effects.
Method: Literature review and summary of existing evidence.
Results: Several medications used as pediatric sleep aids have side effects that range from inconvenient constitutional symptoms, major systemic cardiac, endocrinological and neurological symptoms to potentially fatal syndromes.
Conclusion: Clinicians need to be vigilant for adverse effects of these medications and to implement strategies to mitigate some of the effects, while educating patients and families about the pros and cons of medication use for insomnia.
Keywords: Insomnia, children and adolescents, psychopharmacology, side effects, medications, endocrinological and neurological symptoms.
Current Psychopharmacology
Title:Management of Adverse Effects of Sleep Medications in Pediatrics
Volume: 7
Author(s): Neelkamal Soares*Shibani Kanungo
Affiliation:
- Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker School of Medicine, Kalamazoo, MI, 49008,United States
Keywords: Insomnia, children and adolescents, psychopharmacology, side effects, medications, endocrinological and neurological symptoms.
Abstract: Background: There are no published guidelines for the pharmacological management of insomnia in the pediatric population, and there are no Food and Drug Administration (FDA) approved medications for this purpose. Yet, many classes of psychopharmacological medications are used off-label in children and adolescents.
Objective: To describe the side effects of different classes of medications used as sleep aids in the pediatric population, and management of those side effects.
Method: Literature review and summary of existing evidence.
Results: Several medications used as pediatric sleep aids have side effects that range from inconvenient constitutional symptoms, major systemic cardiac, endocrinological and neurological symptoms to potentially fatal syndromes.
Conclusion: Clinicians need to be vigilant for adverse effects of these medications and to implement strategies to mitigate some of the effects, while educating patients and families about the pros and cons of medication use for insomnia.
Export Options
About this article
Cite this article as:
Soares Neelkamal *, Kanungo Shibani , Management of Adverse Effects of Sleep Medications in Pediatrics, Current Psychopharmacology 2018; 7 (1) . https://dx.doi.org/10.2174/2211556007666180131153440
DOI https://dx.doi.org/10.2174/2211556007666180131153440 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cancellers - Exploring the Possibility of Receptor Decoy Traps As a Superior Anti-Retroviral Strategy
Current Drug Targets Optimized Feature Selection for Enhanced Epileptic Seizure Detection
Current Medical Imaging Hematopoietic Progenitor and Stem Cells Circulate by Surfing on Intracellular Ca2+ Waves: A Novel Target for Cell-based Therapy and Anti-cancer Treatment?
Current Signal Transduction Therapy The Oxygen Therapy
Current Medicinal Chemistry Plasma Glucose Concentrations and Cardiac Hypertrophy in Essential Hypertension
Current Hypertension Reviews Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia
Current Pharmaceutical Design The Topology and Dynamics of Protein Complexes: Insights from Intra– Molecular Network Theory
Current Protein & Peptide Science Potent Neuroprotective Activity of Monoterpene Derived 4-[(3aR,7aS)- 1,3,3a,4,5,7a-Hexahydro-3,3,6-trimethylisobenzofuran-1-yl]-2-methoxyphenol in MPTP Mice Model
Letters in Drug Design & Discovery Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins
Current Pharmaceutical Design Misfolded Proteins and Human Diseases
Protein & Peptide Letters The Role of Sodium Channels in the Mechanism of Action of Antidepressants and Mood Stabilizers
Current Drug Targets Mitochondriotropic Cationic Vesicles A Strategy Towards Mitochondrial Gene Therapy
Current Pharmaceutical Biotechnology Design of Broad-Spectrum Inhibitors of Influenza A Virus M2 Proton Channels: A Molecular Modeling Approach
Current Computer-Aided Drug Design The Development of New Oximes and the Evaluation of their Reactivating, Therapeutic and Neuroprotective Efficacy Against Tabun
Mini-Reviews in Medicinal Chemistry Medical and Dental Implications of Down Syndrome: A Review Part 1: General and Craniofacial Characteristic
Applied Clinical Research, Clinical Trials and Regulatory Affairs Lipid Rafts and Fas/CD95 Signaling in Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Editorial [ Hot Topic: Past, Present and Future in the Treatment of Major Psychotic Disorders (Executive Guest Editor: Konstantinos N. Fountoulakis)]
Current Pharmaceutical Design Neuroleptics and Migraine
Central Nervous System Agents in Medicinal Chemistry Targets to Tackle – The Pathophysiology of the Disease
Current Drug Targets Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
Current Neuropharmacology